![Anti-ANGPTL4 nanobody [SAA1258] (STJN000300)](https://cdn11.bigcommerce.com/s-zso2xnchw9/images/stencil/124x110/products/200913/413095/STJN000300-SDS-PAGE-1__38646.1749232597.jpg?c=1 "Anti-ANGPTL4 nanobody [SAA1258] (STJN000300)")
![Anti-ANGPTL4 nanobody [SAA1258] (STJN000300)](https://cdn11.bigcommerce.com/s-zso2xnchw9/images/stencil/1280x1280/products/200913/413095/STJN000300-SDS-PAGE-1__38646.1749232597.jpg?c=1 "Anti-ANGPTL4 nanobody [SAA1258] (STJN000300)")
Anti-ANGPTL4 nanobody [SAA1258] (STJN000300)
SPECIFICATIONS
ClonalityMonoclonal
HostAlpaca
ConjugationUnconjugated
IsotypeVHH-8His-Cys-tag
General Information
| Short Description | Alpaca monoclonal nanobody anti-Angiopoietin-Related Protein 4 is suitable for use in ELISA research applications. |
| Applications | ELISA |
| Host | Alpaca |
| Reactivity | Human |
| Note | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Product Properties
| Clonality | Monoclonal |
| Clone ID | SAA1258 |
| Isotype | VHH-8His-Cys-tag |
| Conjugation | Unconjugated |
| Concentration | 1 mg/mL |
| Purification | Purified by Nickel column. |
| Formulation | 0.01M PBS, pH 7.4. |
| Storage Instruction | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at-20°C 12 months. Store at-80°C long term. |
Target Information
| Gene Symbol | ANGPTL4 |
| Gene ID | 51129 |
| Uniprot ID | ANGL4_HUMAN |
Additional Info
| Post Translational Modifications | N-glycosylated. ANGPTL4 N-terminal chain: Forms disulfide-linked dimers and tetramers. Cleaved into a smaller N-terminal chain and a larger chain that contains the fibrinogen C-terminal domain.both cleaved and uncleaved forms are detected in the extracellular space. The cleaved form is not present within the cell. |
| Function | Mediates inactivation of the lipoprotein lipase LPL, and thereby plays a role in the regulation of triglyceride clearance from the blood serum and in lipid metabolism. May also play a role in regulating glucose homeostasis and insulin sensitivity (Probable). Inhibits proliferation, migration, and tubule formation of endothelial cells and reduces vascular leakage. Upon heterologous expression, inhibits the adhesion of endothelial cell to the extracellular matrix (ECM), and inhibits the reorganization of the actin cytoskeleton, formation of actin stress fibers and focal adhesions in endothelial cells that have adhered to ANGPTL4-containing ECM (in vitro). Depending on context, may modulate tumor-related angiogenesis. ANGPTL4 N-terminal chain: Mediates inactivation of the lipoprotein lipase LPL, and thereby plays an important role in the regulation of triglyceride clearance from the blood serum and in lipid metabolism. Has higher activity in LPL inactivation than the uncleaved protein. |
| Protein Name | Angiopoietin-Related Protein 4Angiopoietin-Like Protein 4Hepatic Fibrinogen/Angiopoietin-Related ProteinHfarp Cleaved Into - Angptl4 N-Terminal Chain - Angptl4 C-Terminal Chain |
| Database Links | Reactome: R-HSA-1989781Reactome: R-HSA-381340Reactome: R-HSA-8963889Reactome: R-HSA-9762292Reactome: R-HSA-9841922 |
| Cellular Localisation | SecretedExtracellular SpaceExtracellular MatrixThe Unprocessed Form Interacts With The Extracellular MatrixThis May Constitute A Dynamic ReservoirA Regulatory Mechanism Of The Bioavailability Of Angptl4 (Probable) |
| Alternative Nanobody Names | Anti-Angiopoietin-Related Protein 4 nanobodyAnti-Angiopoietin-Like Protein 4 nanobodyAnti-Hepatic Fibrinogen/Angiopoietin-Related Protein nanobodyAnti-Hfarp Cleaved Into - Angptl4 N-Terminal Chain - Angptl4 C-Terminal Chain nanobodyAnti-ANGPTL4 nanobodyAnti-ARP4 nanobodyAnti-HFARP nanobodyAnti-PGAR nanobodyAnti-PP1158 nanobodyAnti-PSEC0166 nanobodyAnti-UNQ171 nanobodyAnti-PRO197 nanobody |
Information sourced from Uniprot.org